《全日速報》恆指全日收報15,879點 升132點; 恆生科技指數全日收報3,197點 升70點 美團升逾5% 美高梅中國、新東方創新高
恆指全日收15,879點,升132點或0.8%。恆生科技指數報3,197點,升70點或2.3%。國指升79點或1.5%,報5,386點。大市成交額570.64億元。
活躍重磅股表現:
美團(03690.HK) 收71.1元,上升5.6%;
阿里巴巴(09988.HK) 收70.8元,上升2.2%;
平安(02318.HK) 收33.45元,上升1.5%;
建行(00939.HK) 收4.66元,上升1.1%;
騰訊(00700.HK) 收290元,上升1%;
港交所(00388.HK) 收243.6元,上升0.4%;
友邦(01299.HK) 收62.7元,下跌0.2%;
異動恆指及國指成份股:
藥明康德(02359.HK) 收38.45元,下跌18.6%;
藥明生物(02269.HK) 收15.72元,下跌9.2%;
小鵬汽車(09868.HK) 收34.8元,上升7.9%;
碧桂園服務(06098.HK) 收5.59元,上升5.5%;
翰森製藥(03692.HK) 收12.86元,上升5.4%;
招行(03968.HK) 收30.25元,上升5%;
攜程集團-S(09961.HK) 收317.2元,上升4.4%;
東方海外(00316.HK) 收109.5元,上升3.8%;
京東集團(09618.HK) 收89.1元,上升3.5%;
銀娛(00027.HK) 收44.35元,上升3.5%;
申洲(02313.HK) 收66.25元,上升3.1%;
異動綜合中小型股:
華南城(01668.HK) 收0.134元,下跌36.8%;
思派健康(00314.HK) 收8.03元,上升21.1%;
衛龍美味(09985.HK) 收6.53元,上升12.2%;
美高梅中國(02282.HK) 收12.32元,上升9.6%,創新高;
新東方(09901.HK) 收69.85元,上升2.9%,創新高;
~
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.